Results 51 to 60 of about 8,503,937 (347)

Implications of Renal Denervation Therapy in Patients with Sleep Apnea

International Journal of Hypertension, 2015
Obstructive sleep apnea (OSA) syndrome is a prevalent condition characterized by repeated episodes of obstruction of the upper airway, leading to intermittent hypoxemia and important endothelial and anatomical dysfunctions that cause cardiovascular and ...
Fernando Jaén-Águila, José Antonio Vargas-Hitos, Juan Diego Mediavilla-García   +2 more
doaj   +1 more source

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

New England Journal of Medicine, 2016
BACKGROUND The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown.
S. Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R. Poulter, Lasse S Ravn, William M Steinberg, M. Stockner, B. Zinman, R. Bergenstal, J. B. Buse   +14 more
semanticscholar   +1 more source

Psoriasis and Cardiovascular Risk: A Comprehensive Review

Advances in Therapy, 2020
Psoriasis is a systemic inflammatory disorder that involves complex pathogenic interactions between the innate and adaptive immune systems. Individuals with psoriasis have an increased risk of developing other chronic health diseases such cardiovascular ...
W. Masson, M. Lobo, G. Molinero
semanticscholar   +1 more source

Cardiovascular risk protection from the Mediterranean diet and olive oil. A transcriptomic update in humans

Grasas y Aceites, 2016
This review highlights the human studies that explore the benefits of the Mediterranean diet and olive oil, based on gene expression analysis. We summarized consistent human transcriptomic studies on cardiovascular risk, based on TMD and olive oil ...
S. Carrión, L. Torres, O. Castañer
doaj   +1 more source

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

New England Journal of Medicine, 2016
BACKGROUND Regulatory guidance specifies the need to establish cardiovascular safety of new diabetes therapies in patients with type 2 diabetes in order to rule out excess cardiovascular risk.
S. Marso, S. Bain, A. Consoli, F. Eliaschewitz, E. Jódar, Lawrence A Leiter, I. Lingvay, J. Rosenstock, J. Seufert, M. Warren, V. Woo, O. Hansen, A. Holst, Jonas Pettersson, T. Vilsbøll   +14 more
semanticscholar   +1 more source

The power of microRNA regulation—insights into immunity and metabolism

FEBS Letters, EarlyView.
MicroRNAs are emerging as crucial regulators at the intersection of metabolism and immunity. This review examines how miRNAs coordinate glucose and lipid metabolism while simultaneously modulating T‐cell development and immune responses. Moreover, it highlights how cutting‐edge artificial intelligence applications can identify miRNA biomarkers ...
Stefania Oliveto, Nicola Manfrini, Stefano Biffo   +2 more
wiley   +1 more source

Chronic kidney disease progression in patients with previous type 2 diabetes and/or hypertension: a population-based cohort study from primary care in Spain

BMJ Open
Objectives To evaluate whether between hypertension and type 2 diabetes (T2D)—established drivers of chronic kidney disease (CKD) progression—one might be more strongly associated with CKD progression than the other.Design Cohort study using a primary ...
David Vizcaya, Betlem Salvador-González, Oriol Cunillera-Puértolas, Sílvia Cobo-Guerrero, José Romano-Sánchez, Daniel Bundó-Luque, Ariadna Arbiol-Roca   +6 more
doaj   +1 more source

Health Disparities in COVID-19: Addressing the Role of Social Determinants of Health in Immune System Dysfunction to Turn the Tide

Frontiers in Public Health, 2020
It is evident that health disparities exist during the COVID-19 pandemic, a pandemic caused by the novel coronavirus SARS-CoV-2. Underlying reasons for COVID-19 health disparities are multi-factorial.
Yvonne Baumer, Nicole Farmer, Thomas A. Premeaux, Gwenyth R. Wallen, Tiffany M. Powell-Wiley, Tiffany M. Powell-Wiley   +5 more
doaj   +1 more source

The Evolving Understanding and Approach to Residual Cardiovascular Risk Management

Frontiers in Cardiovascular Medicine, 2020
Despite unprecedented advances in treatment of atherosclerotic cardiovascular disease, it remains the leading cause of death and disability worldwide. Treatment of major traditional risk factors, including low-density lipoprotein-cholesterol, serves as ...
Devinder S. Dhindsa, P. Sandesara, M. Shapiro, N. Wong   +3 more
semanticscholar   +1 more source

Genes and cardiovascular risk [PDF]

European Heart Journal, 2012
This editorial refers to ‘Influence of common genetic variation on blood lipid levels, cardiovascular risk, and coronary events in two British prospective cohort studies’[†][1], by S. Shah et al. , 972 and ‘Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study’[‡][2], by J.C ...
openaire   +3 more sources